A mechanism of resistance to gefitinib mediated by cellular reprogramming and the acquisition of an FGF2-FGFR1 autocrine growth loop
2013 · Oncogenesis · 255 citations
https://doi.org/10.1038/oncsis.2013.4
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
3
Papers
302
Citations
2
h-index
2
i10-index
K E Ware is an academic researcher. The author has contributed to research in topics: Prostate Cancer Treatment and Research & Pancreatic and Hepatic Oncology Research & Cancer Cells and Metastasis. The author has an h-index of 2, co-authored 3 publications.
https://doi.org/10.1038/oncsis.2013.4
https://doi.org/10.1038/onc.2015.497
Click to start Chat